NIH U01: Research Project Cooperative Agreement

What Makes a Cooperative Agreement Different from a Grant

A standard NIH grant (like an R01) is largely hands-off once awarded: NIH provides funding and oversight through progress reports, but the PD/PI directs the science. A U01 cooperative agreement changes that relationship. NIH program staff have substantial programmatic involvement throughout the project, which can include:

• Joint decision-making — NIH program staff participate in shaping project direction, not just monitoring it after the fact
• Regular collaboration — expect ongoing engagement with NIH program staff over the life of the award, not just at renewal
• A possible NIH co-investigator role — some U01 NOFOs define an active scientific role for NIH staff on the project
• Milestone-driven structure — progress is tracked against defined, objective milestones rather than open-ended progress narratives

Application Format and Page Limits

U01 applications follow the same SF424 (R&R) and PHS 398 Research Plan structure used across most NIH research mechanisms. Several core components carry the same standardized limits that apply across NIH activity codes generally:

• Project Summary/Abstract — 30 lines of text
• Project Narrative — 3 sentences describing public health relevance
• Specific Aims — 1 page
• Biographical Sketches — Common Forms via SciENcv (no hard page limit); ORCID linked to eRA Commons required for due dates on or after January 25, 2026
• Research Strategy (Significance, Innovation, Approach) — not a fixed NIH-wide page limit; the exact limit is set by the specific NOFO, so this is one of the first things to confirm before drafting

Milestones, Governance, and Multi-Site Coordination

Because U01s are frequently used for multi-site or collaborative research, the application needs to address coordination explicitly, not just the science. The Research Strategy should include a consolidated timeline with objective, measurable milestones and, where applicable, describe governance structures such as steering committees and the cadence of required meetings with NIH program staff. Several attachments exist specifically to support this structure and only apply if relevant to your project:

• Multiple PD/PI Leadership Plan — required when multiple PD/PIs are designated; roughly 1 page covering roles, decision-making, communication, and conflict resolution
• Consortium/Contractual Arrangements — describes each partner site's scope of work, budget allocation, and oversight when subawards or multi-institution collaboration are involved
• Resource Sharing — any sharing plans required by policy or the NOFO beyond the Data Management & Sharing Plan (for example, genomic data or model organism sharing)

How Review Differs from a Standard R01

U01 applications are reviewed under NIH's 3-factor Simplified Peer Review Framework, the same framework used for R01, R03, R15, R21, R33, and R61 applications: Factor 1 (Importance of the Research), Factor 2 (Rigor and Feasibility), and Factor 3 (Expertise and Resources, assessed as appropriate rather than scored numerically). What changes for a U01 is what reviewers are asked to weigh within those same three factors:

• Factor 2 additions — the milestone plan for cooperative work, and the governance structure for multi-site or consortium elements if present
• Factor 3 additions — prior experience with NIH cooperative agreements or other large collaborative grants, plus the data-sharing infrastructure and communication plan between sites or collaborators
• Net effect — the coordination and management plan, milestone structure, and team experience with cooperative mechanisms become additional weighted factors within Factor 2 and Factor 3, on top of the same scientific merit review an R01 receives

Data Management and Required Compliance Attachments

A Data Management & Sharing Plan is mandatory for U01 applications, attached under Other Plan(s) per NIH's DMS Policy (effective January 25, 2023). It must address data types and volume, tools and standards, preservation and access timelines, reuse considerations, and oversight; any allowable DMS costs belong in the application budget, not in the plan itself. Depending on the project, additional compliance attachments may also be required: PHS Human Subjects and Clinical Trials Information (with inclusion enrollment tables) if human subjects are involved, Vertebrate Animals if the project uses live animals, and Authentication of Key Biological and/or Chemical Resources (about 1 page) when the work depends on specific reagents, cell lines, or other resources that need verification.